Trials / Withdrawn
WithdrawnNCT02041000
Adipose Derived Cells for Chronic Obstructive Pulmonary Disease
An Open-label, Non-Randomized, Multi-Center Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells Delivered Intravenously in Patients With Chronic Obstructive Pulmonary Disease
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Bioheart, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The intent of this clinical study is to answer the questions: 1) Is the proposed treatment safe and 2) Is treatment effective in improving the disease pathology of patients with diagnosed with chronic obstructive pulmonary disease (COPD).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Adipose Derived Stem Cells |
Timeline
- Start date
- 2014-01-01
- Primary completion
- 2017-01-01
- First posted
- 2014-01-20
- Last updated
- 2017-03-16
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02041000. Inclusion in this directory is not an endorsement.